Published online Mar 28, 2026. doi: 10.3748/wjg.v32.i12.113927
Revised: November 9, 2025
Accepted: February 5, 2026
Published online: March 28, 2026
Processing time: 193 Days and 12.8 Hours
Screening by colonoscopy plays a pivotal role in the decreasing incidence and mortality rates associated with colorectal cancer. However, studies continue to highlight significant miss rates in standard colonoscopy. To address this chal
To evaluate the real-world effectiveness and safety profile of the Endocuff.
We conducted a non-randomized prospective trial by recruiting consenting and eligible participants aged 18+ years (n = 375) undergoing a colonoscopy at the Montfort Hospital (Ontario, Canada). The Endocuff Vision was used in all colonoscopies. Primary outcomes assessed the Endocuff’s polyp detection rate compared to retrospective controls of standard colonoscopy dating up to 5 years. The control cohort (n = 375) was established by sample-matching. Secondary outcomes included safety and patient tolerance.
Colonoscopy with Endocuff in our study yielded a significantly lower overall polyp detection rate compared to controls (72.2% vs 88.7%, P < 0.01). The Endocuff device was well tolerated (94.7%), with no adverse events reported.
In this real-world study, Endocuff-enhanced colonoscopy was not superior to standard colonoscopy. Further larger scale studies with our population are required to validate findings.
Core Tip: The Endocuff device has been previously shown to improve polyp detection in screening colonoscopy. We de
